Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 172 Total
DCPH - Deciphera Pharmaceuticals Inc - Stock Price Chart
TickerDCPH [NASD, RUT]
CompanyDeciphera Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap2.07BEPS (ttm)-2.29
P/E-EPS this Y6.14%
Forward P/E-EPS next Y20.73%
PEG-EPS past 5Y4.07%
P/S12.69EPS next 5Y21.00%
P/B5.78EPS Q/Q9.42%
Dividend-Sales Q/Q32.88%
Insider Own38.85%Inst Own62.71%
Insider Trans-0.33%Inst Trans1.37%
Short Float11.45%EarningsFeb 06/b
Analyst Recom1.55Target Price23.45
Avg Volume516.13K52W Range9.90 - 17.73
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kelly Thomas PatrickChief Financial OfficerFeb 16 '24Sale15.623,01047,00980,350Feb 20 04:05 PM
Sherman Matthew LEVP & Chief Medical OfficerFeb 16 '24Sale15.622,61540,840108,739Feb 20 04:06 PM
Pitman JamaSVP, Chief Development OfficerFeb 16 '24Sale15.622,26735,40568,031Feb 20 04:05 PM
Martin Daniel C.Chief Commercial OfficerFeb 16 '24Sale15.622,26735,40555,118Feb 20 04:05 PM
Kelly Thomas PatrickChief Financial OfficerJan 16 '24Sale14.472,43535,23466,085Jan 18 04:15 PM
SLNO - Soleno Therapeutics Inc - Stock Price Chart
TickerSLNO [NASD]
CompanySoleno Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.74BEPS (ttm)-2.98
P/E-EPS this Y33.76%
Forward P/E-EPS next Y51.81%
PEG-EPS past 5Y24.34%
P/S-EPS next 5Y15.00%
P/B10.46EPS Q/Q43.56%
Dividend-Sales Q/Q-
Insider Own39.22%Inst Own58.30%
Insider Trans-2.37%Inst Trans-0.96%
Short Float15.28%EarningsMar 06/a
Analyst Recom1.00Target Price64.33
Avg Volume309.35K52W Range3.16 - 53.82
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anish BhatnagarCHIEF EXECUTIVE OFFICERApr 01 '24Sale41.3418,980784,645152,790Apr 03 09:36 PM
Mackaness James HCHIEF FINANCIAL OFFICERApr 01 '24Sale41.345,175213,93762,953Apr 03 09:39 PM
Hirano Patricia CSEE REMARKSApr 01 '24Sale41.342,21891,69441,812Apr 03 09:37 PM
Yen KristenSEE REMARKSApr 01 '24Sale41.342,21891,69423,422Apr 03 09:40 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERJan 25 '24Sale48.302,527122,054171,770Jan 29 05:42 PM
PHG - Koninklijke Philips N.V. ADR - Stock Price Chart
TickerPHG [NYSE]
CompanyKoninklijke Philips N.V. ADR
CountryNetherlands
IndustryMedical Devices
Market Cap25.21BEPS (ttm)-0.54
P/E-EPS this Y11.82%
Forward P/E15.89EPS next Y17.17%
PEG-EPS past 5Y-
P/S1.28EPS next 5Y15.56%
P/B1.90EPS Q/Q-
Dividend3.18%Sales Q/Q5.04%
Insider Own0.00%Inst Own7.60%
Insider Trans-Inst Trans-26.40%
Short Float0.42%EarningsApr 29/b
Analyst Recom3.38Target Price22.00
Avg Volume1.05M52W Range17.75 - 24.27
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
IBRX - ImmunityBio Inc - Stock Price Chart
TickerIBRX [NASD, RUT]
CompanyImmunityBio Inc
CountryUSA
IndustryBiotechnology
Market Cap6.36BEPS (ttm)-1.13
P/E-EPS this Y35.22%
Forward P/E-EPS next Y30.20%
PEG-EPS past 5Y1.17%
P/S10260.35EPS next 5Y-1.70%
P/B-EPS Q/Q-29.72%
Dividend-Sales Q/Q90.41%
Insider Own79.68%Inst Own8.46%
Insider Trans0.00%Inst Trans10.14%
Short Float40.05%Earnings-
Analyst Recom2.00Target Price7.50
Avg Volume5.41M52W Range1.25 - 7.74
Apr-25-24 12:03AM ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer (Business Wire) +6.02%
Apr-23-24 04:55PM ImmunityBio's bladder cancer therapy wins FDA approval (Yahoo Finance Video) +11.13%
Apr-22-24 09:56PM ImmunityBio Announces FDA Approval of ANKTIVA, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (Business Wire) -6.26%
Apr-19-24 11:02AM 12 Most Shorted Stocks in 2024 (Insider Monkey) +7.33%
Mar-19-24 09:53PM IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
Mar-14-24 08:45AM Biotech's Role in Addressing the Pancreatic Cancer Emergency (PR Newswire)
Mar-06-24 09:00AM NIAID-Sponsored Study Shows N-803 Combined with Neutralizing Antibodies Could Lead to Sustained HIV Viral Control After Discontinuation of Antiretroviral Therapy (Business Wire) +5.39%
Mar-05-24 09:00AM N-803 Combined with Natural Killer Cells Showed Potential to Reduce HIV Viral Load in HIV Positive Subjects; Part of HIV Cure Study (Business Wire)
Feb-21-24 09:00AM ImmunityBio Announces Full Accrual of First Two Phases of Cancer Vaccine Trial in Participants with Lynch Syndrome and Initiation of Randomized Controlled Phase of the Trial (Business Wire)
Feb-05-24 09:00AM ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the 71% Complete Responders Suggesting a Favorable Risk-Benefit Ratio for N-803 Plus BCG (Business Wire)
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adcock RichardCEO & PresidentFeb 05 '24Option Exercise0.0083,3340286,303Feb 06 09:14 PM
LAUER REGAN JChief Accounting OfficerJan 31 '24Option Exercise0.0032,8720107,804Feb 02 07:32 PM
Sachs David C.Chief Financial OfficerJan 31 '24Option Exercise0.0070,7450212,673Feb 02 07:33 PM
Simon Barry J.DirectorJan 31 '24Option Exercise0.0057,20003,145,855Feb 02 07:38 PM
Adcock RichardCEO & PresidentDec 31 '23Option Exercise0.0034,4830220,065Jan 03 09:40 PM
RYDE - Ryde Group Ltd. - Stock Price Chart
TickerRYDE [AMEX]
CompanyRyde Group Ltd.
CountrySingapore
IndustrySoftware - Application
Market Cap78.64MEPS (ttm)-0.24
P/E-EPS this Y68.39%
Forward P/E-EPS next Y61.11%
PEG-EPS past 5Y-
P/S10.17EPS next 5Y-
P/B-EPS Q/Q-49.14%
Dividend-Sales Q/Q52.36%
Insider Own59.60%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.14%Earnings-
Analyst Recom1.00Target Price8.02
Avg Volume303.97K52W Range2.02 - 8.12
Ryde Group Ltd. provides mobility and quick commerce solutions to its consumers through its subsidiaries. The company was founded on February 21, 2023 and is headquartered in Singapore.
HWH - HWH International Inc. - Stock Price Chart
TickerHWH [NASD]
CompanyHWH International Inc.
CountryUSA
IndustryLeisure
Market Cap36.49MEPS (ttm)0.06
P/E35.15EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.57EPS Q/Q-453.70%
Dividend-Sales Q/Q-
Insider Own86.76%Inst Own9.29%
Insider Trans0.00%Inst Trans5.28%
Short Float5.37%Earnings-
Analyst Recom-Target Price-
Avg Volume862.18K52W Range0.75 - 15.04
HWH International, Inc. operates as a lifestyle business through a membership model. It enables home-based people in the new GIG economy to create lasting wealth. Its segments include HWH Marketplace, Hapi Cafe, Hapi Travel Destinations, and Hapi Wealth Builder. HWH Marketplace offers discounted sale of certain products, manufactured by affiliate company, Sharing Services Global Corp., to members. Hapi Cafe offers location-based social experiences where members can build a sense of community with like-minded customers with a potential interest in the same products. Hapi Travel Destinations aims to offer exclusive access to unpublished rates and discounts on air travel, cruises, car rentals, hotels, and resorts for members. Hapi Wealth Builder is exploring options of providing services to members through educational materials and seminars aimed at various types of investing opportunities. The company is headquartered in Bethesda, MD.
MULN - Mullen Automotive Inc - Stock Price Chart
TickerMULN [NASD]
CompanyMullen Automotive Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap25.54MEPS (ttm)-2356.61
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y44.05%
P/S69.02EPS next 5Y-
P/B0.11EPS Q/Q99.75%
Dividend-Sales Q/Q-
Insider Own1.68%Inst Own11.68%
Insider Trans0.00%Inst Trans-
Short Float20.95%Earnings-
Analyst Recom-Target Price5.17
Avg Volume905.15K52W Range2.36 - 2250.00
Mullen Automotive Inc. operates as an electric vehicle company, which engages in the manufacture of passenger electric vehicles and commercial vehicles. It operates through the Bollinger and Mullen/ELMS segments. The company was founded by David Michery on April 20, 2010 and is headquartered in Brea, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Michery DavidCEO, PresidentAug 16 '23Buy0.98102,040100,4281,322,083Aug 17 06:11 AM
MTC - Mmtec Inc - Stock Price Chart
TickerMTC [NASD]
CompanyMmtec Inc
CountryHong Kong
IndustrySoftware - Application
Market Cap702.70MEPS (ttm)-1.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-28.65%
P/S218.23EPS next 5Y-
P/B8.39EPS Q/Q49.86%
Dividend-Sales Q/Q289.48%
Insider Own0.18%Inst Own0.11%
Insider Trans0.00%Inst Trans0.29%
Short Float0.12%Earnings-
Analyst Recom-Target Price-
Avg Volume1.62M52W Range0.36 - 4.86
MMTec, Inc. engages in the holding of equity interest in MM Future. It operates through the following segments: Gujia, MM Future, HC Securities and MMBD Advisory, and MM Global. The Gujia, MM Future, HC Securities and MMBD Advisory segment provide market data services and fund management services. The MM Global segment operates as an introducing broker that clears all transactions through a clearing broker dealer. The company was founded on January 4, 2018 and is headquartered in Beijing, China.
BTOG - Bit Origin Ltd - Stock Price Chart
TickerBTOG [NASD]
CompanyBit Origin Ltd
CountryUSA
IndustryCapital Markets
Market Cap22.16MEPS (ttm)-10.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.13EPS next 5Y-
P/B2.50EPS Q/Q-62.83%
Dividend-Sales Q/Q40.16%
Insider Own11.31%Inst Own0.65%
Insider Trans0.00%Inst Trans-
Short Float6.47%Earnings-
Analyst Recom-Target Price-
Avg Volume504.02K52W Range1.25 - 9.71
Bit Origin Ltd. operates as an emerging growth company which engages in crypto mining business. The firm also actively deploys blockchain technologies, alongside diversified expansion strategies. It has operations in the United States, Canada, and China. The company was founded on January 23, 2018 and is headquartered in New York, NY.
PAHC - Phibro Animal Health Corp. - Stock Price Chart
TickerPAHC [NASD, RUT]
CompanyPhibro Animal Health Corp.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap622.08MEPS (ttm)0.37
P/E42.04EPS this Y-8.88%
Forward P/E12.44EPS next Y11.97%
PEG17.52EPS past 5Y-12.91%
P/S0.63EPS next 5Y2.40%
P/B2.30EPS Q/Q-82.36%
Dividend3.13%Sales Q/Q2.17%
Insider Own50.06%Inst Own51.03%
Insider Trans0.00%Inst Trans-1.80%
Short Float3.10%EarningsMay 08/a
Analyst Recom4.25Target Price10.75
Avg Volume143.28K52W Range9.40 - 15.96
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
1234561018